Physician

Hari Cp Kannam, MD

According to 2025 Medicare claims, Hari Kannam, MD (NPI: 1952542375) practices interventional cardiology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is CITRUS CARDIOLOGY CONSULTANTS, PLLC (NPI: 1669405379; TIN: 59-2123944) and primary practice location at 34452-4716. Kannam is affiliated with the Health First Physicians ACO (ACO ID: A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (ACO ID: D0048), participating under both the MSSP and REACH models.

Kannam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,162 traditional Medicare patients, billed 8,435 HCPCS/CPT codes, and received $768,688 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 4,800 prescription claims across 818 beneficiaries totaling $877,127 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 13 claims. Open Payments data shows 22 records totaling $437. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $100,448 to $877,127. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,116	4,058	$510,583
2016	1,581	5,168	$624,905
2017	2,070	6,527	$715,358
2018	2,099	6,826	$823,197
2019	2,299	6,597	$706,041
2020	1,996	7,037	$708,369
2021	2,121	8,024	$904,372
2022	2,153	8,096	$690,806
2023	2,596	9,158	$662,559
2024	2,162	8,435	$768,688

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	302	1,422	$100,448
2016	345	1,707	$99,454
2017	375	1,888	$153,750
2018	456	2,344	$163,224
2019	503	2,721	$282,435
2020	555	3,434	$367,028
2021	627	3,843	$409,713
2022	686	4,112	$517,104
2023	710	3,860	$597,043
2024	818	4,800	$877,127

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	18	$39,868
2022	N/R	13	$31,136
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	318	319	$202
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	516	554	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	518	974	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	289	388	$14
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,115	1,884	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	353	19,001	$358,460
Entresto	Sacubitril/Valsartan	143	7,978	$169,080
Xarelto	Rivaroxaban	97	5,707	$102,124
Farxiga	Dapagliflozin Propanediol	108	4,920	$89,034
Repatha Sureclick	Evolocumab	55	2,352	$43,630

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$437	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hari Cp Kannam, MD?

Tedicare shows public-source Medicare data for Hari Cp Kannam, MD (NPI 1952542375), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hari Cp Kannam, MD have ACO affiliation data?

Hari Cp Kannam, MD is shown with ACO affiliation data for Health First Physicians ACO (MSSP, ACO ID A5451) and Pathways Accountable Care, LLC d/b/a Pathways Health Partners (REACH, ACO ID D0048).

What billing organization is linked to Hari Cp Kannam, MD?

Hari Cp Kannam, MD is linked to CITRUS CARDIOLOGY CONSULTANTS, PLLC (billing NPI 1669405379) in the available physician profile data.

Does Hari Cp Kannam, MD have Open Payments data?

Hari Cp Kannam, MD has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.